Displaying drugs 14576 - 14600 of 14838 in total
Napabucasin
Napabucasin has been investigated for the treatment of Colorectal Carcinoma.
Investigational
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
Methyl isocyanate
Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.
Investigational
Pridopidine
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational
Oxomemazine
Experimental
9-Deazahypoxanthine
Experimental
Isatoic anhydride
Experimental
REN-850
REN-850 is an oral drug for multiple sclerosis which is in Phase I of clinical trials.
Investigational
3-Aza-2,3-Dihydrogeranyl Diphosphate
Experimental
2-Methyl-3-(2-Aminothiazolo)Propanal
Experimental
2-Dimethylamino-Ethyl-Diphosphate
Experimental
Quinalizarin
Experimental
AP5346
AP5346 is designed to target a diaminocyclohexane platinum (Pt) moiety to tumors through pH-sensitive linkage to a 25 kDa hydroxypropylmethacrylamide polymer. It is being pursued by Access Pharmaceuticals, Inc.
Investigational
Terevalefim
Terevalefim is under investigation in clinical trial NCT02474667 (Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney).
Investigational
2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE
Experimental
Tiletamine
This drug is a dissociative anesthetic agent that falls under the drug category of NMDA receptor antagonists. Tiletamine is chemically similar to another dissociative anesthetic, ketamine. Tiletamine hydrochloride, the salt form, exists as odorless white crystals.
Vet approved
S,S-Propylthiocysteine
Experimental
indane-5-sulfonamide
Experimental
Displaying drugs 14576 - 14600 of 14838 in total